SCHEMBL21992999

SCHEMBL21992999

COc1ccc2oc(=O)c3c(c2c1)OC(N)=C(C#N)C3c1ccc(OC)c(-c2cccnc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
KMT2A Q03164 6/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
TSHR P16473 2/20 0.57
MAPT P10636 7/20 0.53
MEN1 O00255 5/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
USP7 Q93009 2/20 0.49
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TOP2A P11388 2/20 0.46
LMNA P02545 1/20 0.46
NPC1 O15118 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
GAA P10253 2/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21992989 0.93 KMT2A (0.58) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993282 0.92 KMT2A (0.57) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993456 0.92 KMT2A (0.57) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21992962 0.92 KDM4E (0.68) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993255 0.90 KDM4E (0.57) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993426 0.90 KDM4E (0.55) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993044 0.90 KMT2A (0.61) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21992988 0.90 KMT2A (0.54) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21992979 0.85 KMT2A (0.49) KDM4EKMT2ASMN1; SMN2TSHRMAPT
SCHEMBL21993432 0.85 KDM4E (0.61) KDM4EKMT2ASMN1; SMN2TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2021-10-12 US disclosed
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 ETF1, F3, DNASE1L3 KDM4E 3966/4885KMT2A 4155/4885SMN1; SMN2 3282/4885
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 ETF1, F3, DNASE1L3 KDM4E 3966/4885KMT2A 4155/4885SMN1; SMN2 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.